Non-invasive vagus nerve stimulation (nVNS) for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

"The medical research team are looking for participants aged between 5 and 21 years old."

"Affirmative. According to the details provided by clinicaltrials.gov, this study is currently in search of participants. The original post was put up on February 22nd 2022 and updated most recently on September 2nd 2022; 15 individuals are required from two medical sites for enrolment."

"This experiment is set to observe Change in nerve conduction study F wave latency over a Baseline, Month 12, and Month 24 time frame - its primary outcome. As secondary outcomes will be evaluated the influence of treatment on serum cytokine profiles via measuring TNF-α (Tumor Necrosis Factor Alpha), IL-1β (Interleukin 1 Beta) and HGF (Hepatocyte Growth Factor). Higher levels of these markers are usually associated with CIDP patients; any decrease could indicate that the medication has been effective."

"This clinical trial is seeking 15 children and young adults aged 5-21 suffering from polyradiculoneuropathy, chronic inflammatory demyelinating. To qualify for participation, patients must have a formal diagnosis of CIDP with evidence in their medical record; they are also expected to be receiving treatment using intravenous immunoglobulin (IVIG), steroids or plasma exchange at the time of enrollment."

"Affirmative. The clinical trial's page on clinicialtrials.gov confirms that this medical study, initially listed on February 22nd 2022, is actively enrolling patients. A total of 15 individuals are needed to be recruited from 2 sites."